tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

iBio Regains Nasdaq Compliance with Bid Price Rule

Story Highlights
iBio Regains Nasdaq Compliance with Bid Price Rule

Meet Your ETF AI Analyst

The latest update is out from Ibio ( (IBIO) ).

On November 4, 2025, iBio, Inc. announced that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share. This follows a previous notification on July 29, 2025, indicating non-compliance due to the company’s stock price falling below the required threshold between June 13, 2025, and July 28, 2025. The issue is now resolved, closing the matter.

The most recent analyst rating on (IBIO) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Ibio stock, see the IBIO Stock Forecast page.

Spark’s Take on IBIO Stock

According to Spark, TipRanks’ AI Analyst, IBIO is a Neutral.

IBIO’s overall score is heavily impacted by significant financial challenges, including negative earnings and cash flow issues. The weak technical outlook and poor valuation metrics further weigh down the score. However, recent strategic corporate events provide some optimism for future growth, but they are not enough to offset the current financial difficulties.

To see Spark’s full report on IBIO stock, click here.

More about Ibio

Average Trading Volume: 3,364,796

Technical Sentiment Signal: Sell

Current Market Cap: $35.65M

Learn more about IBIO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1